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Amelogenesis imperfecta (AI) represents a broad
spectrum of genetic diseases aecting enamel for-
mation in both the primary and permanent denti-
tions. AI has been classified into 14 dierent
subtypes according to the clinical appearance of
the enamel and the Mendelian mode of inheritance
(1). The combined prevalence of all forms of AI has
been reported as 1:14,000 in the US (1), 1:8,000 in
Israel (2), 1:4,000 in Sweden (3) and 1:700 in the
Va¨sterbotten county of Sweden (4). The enamel
abnormalities have been categorized into three
major groups, hypocalcified, hypomaturation, or
hypoplastic, and the inheritance patterns reported
include autosomal dominant or recessive, and
X-linked dominant or recessive (1).
The autosomal dominant forms of AI are the
most prevalent forms, representing over 95% of all
reported cases and have been shown to be genetic-
ally heterogeneic (5). To date, a disease locus has
been established for only one type of autosomal
dominant AI, the local hypoplastic form (AIH2).
AIH2 was initially mapped in three Swedish
families to human chromosome 4q11–q21 within
a 17.6 cM region (6). This locus was further refined
to a 4-Mb region located between D4S2421 and
the albumin gene by recombination breakpoint
mapping using six Swedish families (7).
Ameloblastin (Ambn; also known as amelin and
sheathlin) was initially isolated as the most
abundant novel transcript from 400 random rat
incisor cDNAs (8). The clone was 1925 bp, and
contained multiple putative open reading frames
(ORFs) with the longest encoded a 422 amino acid
acidic protein with a reported pI of 5.54 and an
Mr of 45 kDa. Using a similar approach, other
investigators independently cloned two rat tran-
scripts, termed amelin 1 and 2, which code for the
same protein (9). In situ hybridization studies have
shown Ambn to be expressed at high levels by the
enamel-producing ameloblast cells (8–11) with
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Amelogenesis imperfecta is a broad classification of hereditary enamel defects,
exhibiting both genetic and clinical diversity. Most amelogenesis imperfecta cases
are autosomal dominant disorders, yet only the local hypoplastic form has been
mapped to human chromosome 4q between D4S2421 and the albumin gene. An
enamel protein cDNA, termed ameloblastin (also known as amelin and sheathlin),
has been isolated from rat, mouse and pig. Its human homolog has been mapped
to chromosome 4q21 between markers D4S409 and D4S400, flanking the local
hypoplastic amelogenesis imperfecta critical region. Therefore, ameloblastin is a
strong candidate gene for this form of amelogenesis imperfecta. To facilitate genetic
studies related to this dental disease, we isolated and characterized a human
ameloblastin cDNA. A human third molar cDNA library was screened and two
ameloblastin clones identified. Nucleotide sequencing of these cDNAs indicated
alternative splicing of the putative open reading frame, use of dierent
polyadenylation signals, and a high degree of similarity to reported rat, mouse
and porcine cDNAs. Immunohistochemistry studies on embryonic human teeth
using an antibody to recombinant ameloblastin indicated ameloblastin expression
by ameloblasts with localization in the enamel matrix associated with the sheath
structures.
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moderate expression by the Hertwig epithelial root
sheath (12, 13) and transient expression by pre-
odontoblasts (13). Immunohistochemistry has
demonstrated localization to the ameloblast cell
layer, with intense staining in the distal cytoplasm
of ameloblasts, the Tomes processes of secretory
ameloblasts, and within the matrix at the dentino-
enamel junction (DEJ) (8, 10, 13–15) with limited
expression in early preodontoblasts (13). Rat and
mouse Ambn cDNAs (8, 9, 16) showed homology
with the sequence of a 15-kDa enamel matrix
sheath protein (14) identified by biochemical ana-
lysis of enamel matrix, as well as the corresponding
porcine cDNA termed sheathlin (17).
The mouse Ambn locus has been mapped to
chromosome 5, distal to the Kit gene (8). More
precise mapping of the human AMBN locus using
two-color fluorescence in situ hybridization has
placed the gene on the long arm of human chromo-
some 4, between the sequence tagged site (STS)
markers D4S400 and D4S409 (18). This region,
4q13–q21, has been shown to contain the gene locus
for AIH2 (7). Furthermore, a human AMBN
genomic P1 artificial chromosome (PAC) clone was
shown to contain three STS markers, D4S2604,
D4S2670 and D4S2609, previously placed within
the critical AIH2 region as defined by haplotyping
using six Swedish families (18). Therefore, AMBN
appears to be a strong candidate gene for this form
of AI.
To determine the genomic organization of human
AMBN and thereby facilitate genetic studies related
to AIH2, we have isolated and characterized human
Ambn cDNA clones. In addition, the spatial expres-
sion pattern of the translated protein during early
human tooth development has been analyzed.
Material and methods
Labeled Ambn probe
The rat Ambn cDNA (1.9 kb) (8) was labeled to
a high specific activity using the Prime-It II random
priming kit (Stratagene, La Jolla, CA, USA) and
[a-32P]dCTP. The probe was purified using a
Sephadex G-50 column as previously described (16).
Human tooth cDNA library screening
A previously characterized human third molar
cDNA library (19) was plated with host cell
XL1-Blue MRF’ at a density of 56104 plaques
per 150-mm LB plate. Plaques were transferred to
duplicate nylon filters, denatured, neutralized and
rinsed as previously described (19). Damp filters
were ultraviolet (UV)-cross-linked (Stratalinker;
Stratagene) using the auto setting, rinsed in distilled
water, and prehybridized for 2 h at 68‡C in
Quik-Hyb hybridization solution (Stratagene) plus
100 mg/ml of sheared salmon sperm DNA.
Filters were hybridized with labeled rat Ambn
as previously described (16). Blotted filters were
placed on Biomax MR-1 film (Kodak, Rochester,
NY, USA) overnight at ÿ70‡C with intensifying
screens. Putative positive clones (*25 plaques) were
selected and confirmed by polymerase chain reac-
tion (PCR) amplification with an Ambn-specific
primer set as previously described (16). Samples
which were positive for Ambn amplicons were
plated at a density of approximately 100 plaques/
100 mm plate and a secondary screen performed as
described above using a mouse full length Ambn
cDNA probe (16). Six tertiary screened plaques
were picked, and tested for insert length using
PCR with flanking vector-specific primers gener-
ated to the T3 and T7 RNA polymerase promoter
sequences. These clones were rescued to Bluescript
SK(ÿ) phagemids using the Ex-assist Helper Phage
kit (Stratagene).
DNA sequence and analysis
DNA sequence was determined using automated
sequencing (Applied Biosystems, Model 370A) at
the Human Genome DNA Core Laboratory
(University of Texas Health Science Center, San
Antonio, TX, USA). Unresolved DNA sequence
was determined manually using Sequenase 2.0 kit
according to the suppliers instructions (Amersham
USB, Arlington Heights, IL, USA). A contiguous
DNA sequence was generated using the Assembly-
lign program (Kodak) using data from multiple
overlapping sequence reactions. Open reading
frame, protein subsequence, and amino acid con-
tent were analyzed using MacVector 6.0 (Oxford
Molecular, Campbell, CA, USA). Protein align-
ments were generated using the Clustal W (1.4)
feature of MacVector 6.0 using default program
settings. Isoelectric points, and isotope averaged
molecular weight were calculated using MacBiospec
(Perkin-Elmer Sciex, Thornhill, Ontario, Canada).
Immunohistochemistry
Mandibles from fetuses (n~4; 21–26 wk of gesta-
tion) were obtained after pathological diagnosis for
medical reasons, with parental informed signed
consent. This study was performed on a limited
collection under the approved direction of the
French National Ethics committee. Samples were
fixed in buered formaldehyde, decalcification with
nitric acid (Labonor, Paris, France), dehydrated,
paran-embedded and histological sections (5 mm)
prepared. Primary and secondary antibodies, as
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well as conjugated peroxidase, were diluted in a
solution of 0.05 M Tris NaCl, pH 7.6 containing
1% normal goat serum (NGS; Amersham, les
Ulis, France). Washes were performed in 0.05%
Tris NaCl solution, pH 7.6, containing 1% bovine
serum albumin (Sigma, le Verpilliere, France).
Endogenous peroxidases in the tissues were inacti-
vated by treatment with 3% H2O2 for 15 min. The
tissue was then blocked with 10% NGS for 24 h at
4‡C. The primary antibody (1:5,000 dilution) was
incubated for 18 h at 4‡C, biotinylated secondary
antibody (1:800, Sigma) for 30 min, and strept-
avidin peroxidase (1:300, Vector, Paris, France)
for 30 min. Diaminobenzidine was used as the
peroxidase substrate (Sigma). The sections were
counterstained with Harris hematoxylin (Shandon,
Paris, France), dehydrated and mounted. Micro-
graphs were taken with a Zeiss Orthoplan
microscope.
Results
In order to facilitate determination of AMBN
gene structure and mutational analysis for AIH2,
we screened a human third molar cDNA library
using full-length rat and mouse Ambn cDNA
clones. Initial screening of approximately 56104
recombinants resulted in 25 primary clones. Small
aliquots of these primary isolates were initially
confirmed by PCR amplification using an Ambn
primer set based rat cDNA sequence (rAmbnY274S
5’AGATTCCACTTTTCAAAATG3’ and rAmbn-
Y274AS 5’TTCTGGGGTGTGACCCTG3’). Posi-
tive isolates were then subjected to a single
secondary screening at low density using radio-
labeled full-length mouse Ambn cDNA clone (16).
Isolated positive single clones were again amplified
by PCR using vector-specific primers to the insert
flanking T3 and T7 RNA polymerase promoter
segments of the Bluescript SKzvector flanking the
insert in order to determine the approximate cDNA
insert size. Six clones containing the largest inserts
were chosen for further DNA sequence analysis.
These human Ambn clones were rescued to
phagemid, and the DNA sequence of both strands
determined. The longest clone (human 1A2) was
1983 bp exclusive of the poly A tail, and contained
an open reading frame encoding 447 amino acids
(Genebank accession number AF209780). This
clone contained a long untranslated 3’ region with
three potential polyadenylation signals (AATAAA)
(Fig. 1). The putative start site (ATG)was at base 84,
with a potential signal peptide of 26 amino acids.
Selection of this initial methionine (Met) as the start
codon was based on previously published rat and
mouse Ambn sequences (8, 16). Additional clones
identified varied by the inclusion or exclusion of
a 45-bp segment encoding 15 amino acids (98–112)
and the length of the 3’ untranslated region (arrow,
Fig. 1) by the use of the second or third polyadenyla-
tion signals beginning at nucleotides 1615 or 1963,
respectively. The 15-amino acid (45-bp) segment
YEYSLPVHPPPLPSLQ of the human Ambn clone
was 100% conserved with a segment shown to be
alternately spliced at the mRNA level in rat and
mouse Ambn and in pig sheathlin (8, 4, 17). This
segment contained 8.0% of the total proline residues
found in the mature human protein.
Alignment of the predicted amino acid sequence
for human Ambn with published sequences for
pig, mouse and rat cDNA clones is shown in
Fig. 2. This data indicates that Ambn is a highly
conserved protein between the four species studied.
The human Ambn amino acid sequences was more
similar to that of the pig sheathlin than the two
reported rodent clones. Between human and pig,
we found 65% identity with an additional 9%
conservative substitution. The unique five-amino
acid deletion (AQGMA) found in pig sheathlin
beginning at amino acid 35 is also absent in the
human Ambn clone, as well as a single proline
after amino acid 165. In addition, three single
amino acid insertions of glycine (aa 322), phen-
alanine (aa 408), and glutamic acid (aa 436),
and one two-amino acid insert of lysine–glycine
(aa 371–372) are found in the human Ambn
sequence. These insertions are again more similar
to the sequence of pig sheathlin. Most interest-
ing is the insertion of 26 amino acids found
unique to the human AMBN cDNA that is not
contained in any other species. This segment
SLPGMDFPDPQGPSLPGLDFADPQGS) con-
tains an almost perfect double repeat of a 13 amino
acid sequence (amino acids 190–215, underlined).
The potential post-translational modification of
human Ambn by casein kinase II at residue 262
is conserved, as is the tyrosine kinase site at
residue 98.
The predicted mature human protein would have
a calculated isotope-averaged molecular weight of
45.6 kDa and would be weakly acidic with a pI of
6.1. Molecular weight, pI, and amino acid content
of human Ambn is similar to rat, mouse and
porcine proteins (Table 1). Human protein is rich
in proline (15%), glycine (9%), alanine (7.6%),
and leucine (9.7%), with no cysteine found as
previously reported for other species.
Immunolocalization studies were performed
using a previously characterized Ambn antibody
generated against a recombinant rat COOH region
protein (aa 175–348) and therefore able to recog-
nize both isoforms (8). This antibody has
been tested for specificity by Western blot using
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Fig. 1. Composite DNA sequence of human Ambn clones and the deduced amino acid sequence (Genebank accession number
AF209780). The numbering of protein and DNA sequence is shown on the right. The signal peptide is underlined with a single line,
the stop codon is noted by an asterisk. Three polyadenylation signals (AATAAA) are shown in bold, and the 45-bp (15 amino acid)
segment which is alternatively spliced is bold and bold underlined.
Fig. 2. Amino acid alignment using the Clustal W (1.4) software of human, pig sheathlin, mouse and rat Ambn. The blosum identity
matrix was used, with an open gap penalty equal to 10 and an extended gap penalty equal to 0.1. The numbering of the amino acids
for each species is shown on the right. Identities are denoted by an asterisk (*), conserved similarities by a dot (P), and deletions by
a dash (-). The potential NH2-terminus is indicated by an arrow and the conserved alternative splice segment is shown in bold.
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recombinant Ambn protein, extracts of various
tissues and enamel extracellular matrix (Y. Yamada,
unpublished data). At the prenatal stages exam-
ined, Ambn protein was only evident by immuno-
cytochemistry within developing tooth organs.
Ambn immunoreactivity first appeared in the secre-
tion stage ameloblasts. Inside the cell compartment,
Ambn epitopes were exclusively located inside
large, rounded structures at the distal end of the
cell body. Extracellularly, immunoreactive enamel
was present nearby the secretory pole of amelo-
blasts and also in the vicinity of the dentinal-enamel
junction. In the deep layers of forming enamel,
immunoreactivity varied, the prism sheaths were
associated with highest apparent concentrations
with diused staining between these structures.
Faint immunostaining was also present in the
predentin region and within the developing odonto-
blast cell layer facing mantle dentin. However,
staining was not detectable within forming bone,
Meckels cartilage, buccal epithelium, muscles, or
salivary glands.
Discussion
We have identified six human Ambn cDNA clones,
exhibiting alternative splicing and the use of two
dierent polyadenylation signals. Analysis of the
isolated clone showed there was no direct correla-
tion with the inclusion or exclusion of the 45-bp
(15 aa) alternatively spliced segment with utiliza-
tion of a particular polyadenylation signal. The two
alternatively spliced transcripts we report agree
with the Northern blot findings of two rat Ambn
transcripts (1.6 and 2.0 kb) (8). The amino acid
content of high proline (15%), glycine (10%),
alanine (9%), and leucine (9%) for human Ambn
Fig. 3. Immunolocalization of Ambn in a pre-natal human developing tooth germ at 26 weeks. Positive immunoperoxidase staining
using a 1:5000 dilution of the anti-ameloblastin antibody is shown in panels 1 (406), 2 (1006) and 4 (1006). No staining was seen
using a 1:5000 dilution of control IgGs (panel 3, 1006). Ambn immunoreactivity appears located intracellularly within the distal part
of the ameloblast cell body (panels 1 and 2). Extracellularly, positive labeling is seen within the newly forming enamel next to the
ameloblasts and distally at the enamel dentinal junction. Notably, light, sporadic staining of the distal ends of the dentinal tubules
could be seen (panel 1). At high magnification (1006), within the ameloblasts staining appeared associated with distal secretory
granules (panel 2, long arrows). In the extracellular matrix, a more intense staining was found at the prism borders referred to
as ‘‘enamel sheaths’’, while lighter more diuse staining was observed in the remainder of the enamel matrix. Abbreviations:
a, ameloblasts; e, enamel; d, dentin; o, odontoblasts; s, sheaths; and p, prisms.
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remains consistent with that found in other species
(8, 4, 16) as does the calculated pI of 6.1.
The presence of two alternatively spliced tran-
scripts of human Ambn is comparable to that
reported for mouse Ambn (16) and pig sheathlin
sequence (17). The alternatively spliced 45-bp
segment, amino acid sequence YEYSLPVHPPP-
LPSQ, is 100% conserved in all species studied to
date. This homology across vertebrate evolution
suggests a significant functional role for this seg-
ment during amelogenesis. The presence of a unique
5 amino acid insert in mouse and rat Ambn is also
absent in human as reported for pig (17). Most
interesting is the 26 amino acid insertion found
exclusively in the human Ambn sequence. Most
likely, this segment arose through the insertion and
duplication of a smaller 13 amino acid sequence
based on the degree of amino acid similarity. This
segment increases the molecular weight of both
human Ambn isoforms, as well as increasing the
overall acidity of the human protein.
One of the slight ambiguities related to the Ambn
cDNA clones identified to date is the assignment of
the start codon between the first, second or third
Met. The first Met is the start codon (*90% of
eukaryotic mRNAs), and this initial codon is
preceded by a purine (adenine or guanine) in the
(ÿ3) position (*97% of eukaryotic sequences) (20).
This leads to a conflict for all reported Ambn
sequences, where the first Met does not have a
purine at the ÿ3 position. This would support the
assignment of the second Met as the start codon
which does have an adenine in the correct position,
leading to a shorter 16 amino acid signal peptide.
However, at the amino acid level the sequence
between the first and second Met is highly con-
served (8 out of 10 residues) between species,
suggesting utilization of the first Met.
The present investigation demonstrates immuno-
logical cross-reactivity between a polyclonal recom-
binant rat Ambn antibody and native human
Ambn epitopes. This evidence supports the exis-
tence of homologies in these polypeptide regions
between both species. Previously, studies have
shown this same cross-reactivity on human forming
tooth germs at the early bell stage of development
(10). In contrast to the early expression of Ambn
mRNAs at E-14 by RT-PCR analysis (16), the
protein was only detectable in dierentiated amelo-
blasts. However, the detection of early protein
synthesis may be under the threshold of immuno-
histochemistry sensitivity, since decalcification
procedures may delete more than 50% of the
immunoreactive species (21), and human samples
are not ideally preserved in contrast to experi-
mental approaches using animal models where
Table 1
Comparison of the amino acid compositions of Human Ameloblastin clone IA2 with mouse Ambn, rat Ambn and porcine sheathlin.
Analysis is for the secreted protein lacking the signal peptide using MacBiospec software
Human ameloblastin Mouse ameloblastin Rat ameloblastin Pig sheathlin
Amino acid Res/Mol Res/1000 Res/Mol Res/1000 Res/Mol Res/1000 Res/Mol Res/1000
Alanine 32 76 34 86 32 81 31 78
Arginine 13 31 15 38 11 28 14 35
Asparagine 13 31 14 35 14 35 11 28
Aspartic acid 20 48 11 28 12 30 13 33
Cysteine 0 0 0 0 0 0 0 0
Glutamine 28 67 31 78 30 76 31 78
Glutamic acid 25 59 23 58 23 58 23 58
Glycine 38 90 39 98 41 104 46 116
Histidine 11 26 11 28 13 33 6 15
Isoleucine 6 14 9 23 8 20 7 18
Leucine 41 97 36 91 35 88 33 84
Lysine 13 31 9 23 9 23 12 30
Methionine 22 52 15 38 16 40 16 41
Phenylalanine 20 48 16 40 15 38 15 38
Proline 63 150 61 154 63 159 59 149
Serine 29 69 25 63 24 61 31 78
Threonine 20 48 19 48 20 51 18 46
Tryptophan 3 7 3 8 3 8 3 8
Tyrosine 9 21 9 23 10 25 11 28
Valine 15 36 16 40 17 43 15 38
Total 421 1000 396 1000 396 1000 395 1000
pI 6.1 6.5 6.3 6.6
Mr 45,595 42,521 42,358 42,010
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intracardiac perfusions are usually performed
(10, 14, 21, 22).
Comparative data on the cellular and extra-
cellular distribution of Ambn (human, the present
study and rat incisor; 8, 22, 23) shows conservation
among mammals for the respective compartment-
alization of matrix proteins during the process of
enamel formation. In our study, immunoreactivity
for Ambn proteins appeared concentrated in the
prism sheaths of forming enamel, as shown pre-
viously for the NH2-terminal region of rat Ambn
(22) and porcine sheathlin (14). However, the dis-
tribution of immunoreactive species at the secretory
pole of ameloblasts was not related to the forma-
tion of enamel sheath as also seen in rat (22, 23),
but in contrast to localization in pig (14). The
present data support the notion that Ambn may
constitute a functional group of proteins which
contribute to the formation of prism sheaths.
The characterization of the Ambn cDNA
sequence will facilitate determination of the
genomic organization of the gene and future
mutational analyses in patients presenting with
the local hypoplastic form of AI.
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